Liquidia LQDA
NASDAQ LQDA
$68.57 +0.89 (+1.32%)
As of: Sep 9, 2026 · 2:33 PM EDT

Liquidia (LQDA) Accumulated Expenses (2019 - 2026)

Liquidia (LQDA) posted Accumulated Expenses of $121.7 million for Q2 2026, up 38.72% on a QoQ basis from $87.7 million in Q1 2026, and up 440.36% year-over-year from $22.5 million in Q2 2025.

Analysis

Liquidia (LQDA) Accumulated Expenses (2019 - 2026) Analysis & Trends

Liquidia has reported Accumulated Expenses for 8 years, with the latest figure at $121.7 million in Q2 2026.

  • On a quarterly basis, Accumulated Expenses rose 440.36% year-over-year to $121.7 million in Q2 2026; TTM through Jun 2026 was $121.7 million, a 440.36% increase from a year earlier, with the FY2025 full-year figure at $73.2 million, up 292.29% from the prior year.
  • Accumulated Expenses was $121.7 million for Q2 2026 at Liquidia, up from $87.7 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $121.7 million in Q2 2026, with the low at $845000.0 in Q1 2022.
  • Average Accumulated Expenses over 5 years is $26.4 million, with a median of $14.0 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Accumulated Expenses tumbled 43.18% in 2022, then jumped 533.83% in 2026.
  • Over 5 years, Accumulated Expenses stood at $5.5 million in 2022, then jumped by 142.67% to $13.4 million in 2023, then jumped by 39.25% to $18.7 million in 2024, then soared by 292.29% to $73.2 million in 2025, then surged by 66.26% to $121.7 million in 2026.
  • The last three Accumulated Expenses figures came in at $121.7 million (Q2 2026), $87.7 million (Q1 2026), and $73.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn
7 Revolution Medicines 44.12 Bn 44.12 Bn -
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn
10 Liquidia 6.09 Bn 5.80 Bn 160.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.70 Mn
Mar 31, 2026 87.73 Mn
Dec 31, 2025 73.20 Mn
Sep 30, 2025 40.44 Mn
Jun 30, 2025 22.52 Mn
Mar 31, 2025 13.84 Mn
Dec 31, 2024 18.66 Mn
Sep 30, 2024 17.04 Mn
Jun 30, 2024 13.10 Mn
Mar 31, 2024 14.07 Mn
Dec 31, 2023 13.40 Mn
Sep 30, 2023 6.62 Mn
Jun 30, 2023 14.77 Mn
Mar 31, 2023 2.95 Mn
Dec 31, 2022 5.52 Mn
Sep 30, 2022 5.22 Mn
Jun 30, 2022 4.31 Mn
Mar 31, 2022 845,000.00
Dec 31, 2021 5.17 Mn
Sep 30, 2021 2.06 Mn